Cargando…
Glucose-lowering treatments and COVID-19 mortality in T2DM
The poor prognosis in patients with diabetes mellitus who contract COVID-19 urged physicians to question routine drug treatment for people with type 2 diabetes mellitus. What treatment should we prioritize? So far only observational studies are available, although complementary interventional studie...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114189/ https://www.ncbi.nlm.nih.gov/pubmed/33981029 http://dx.doi.org/10.1038/s41574-021-00509-x |